|
![]() |
|||
|
||||
OverviewType 2 diabetes is a chronic metabolic disorder characterized by high levels of blood sugar (glucose) resulting from insulin resistance and inadequate insulin secretion. Insulin is a hormone produced by the pancreas that helps regulate blood sugar by facilitating the uptake of glucose into cells for energy. Tirzepatide, approved by the FDA in May 2022, is a medication for managing type 2 diabetes mellitus. It operates as a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist. Mounjaro is a prescription injectable medication prescribed in conjunction with diet and exercise to enhance blood sugar (glucose) control in adults diagnosed with type 2 diabetes mellitus. Click buy to get this Product Full Product DetailsAuthor: Kemp BurtonPublisher: Independently Published Imprint: Independently Published Dimensions: Width: 15.20cm , Height: 0.20cm , Length: 22.90cm Weight: 0.064kg ISBN: 9798873417339Pages: 38 Publication Date: 30 December 2023 Audience: General/trade , General Format: Paperback Publisher's Status: Active Availability: In Print ![]() This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us. Table of ContentsReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |